Select a community
ALS including PLS and PMA
Find out more about the PatientsLikeMe
ALS Community
Home > Community Treatment Reports > Carbolithium (lithium carbonate) Treatment Report
What is Carbolithium?

A generic brand of lithium carbonate dosed once a day. Lithium is used to treat and prevent episodes of mania in people with bipolar disorder (manic depressive disorder). Lithium is in a class of medications called antimanic agents, which work by decreasing abnormal activity in the brain. Read more...Click to read more below

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Slow my ALS progress 5 1
Other 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
0 0%
None
2 100%

Dosages

  300 mg daily 450 mg daily 600 mg daily 750 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Carbolithium (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
2 100% Did not seem to work: 100%

See all 2 patients who’ve stopped taking Carbolithium

Currently Taking Carbolithium

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
1
0
1
0

Stopped Taking Carbolithium

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
1
0
1
0

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
0 0%
Usually
1 50%
Sometimes
0 0%
Never
1 50%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
1 50%
A little
0 0%
Not at all
1 50%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
2 100%

Research:
Lithium & ALS

See how ALS patients taking lithium are doing in real-time by viewing FRS scores before and after starting lithium. Easily compare individual dosages and blood levels, and filter results by a rich set of patient characteristics.

Icon_bullet_arrow Research: Lithium & ALS

Report created on November 21, 2009.